Literature DB >> 11717613

Usefulness of peak mitral inflow velocity to predict severe mitral regurgitation in patients with normal or impaired left ventricular systolic function.

K Ozdemir1, B B Altunkeser, G Sökmen, M Tokaç, H Gök.   

Abstract

BACKGROUND: The aim of this study was to evaluate the reliability of peak mitral inflow (E-wave) velocity, which was thought to be easier and more practical than qualitative and quantitative methods used to grade mitral regurgitation (MR) in patients both with normal and low left ventricular (LV) ejection fraction (EF). It is known that peak E-wave velocity increases in MR. But correlation of this increase with regurgitant fraction (RF), its usefulness in grading MR, and the effect of EF on peak E-wave velocity have not been studied in detail.
METHODS: We prospectively examined 135 consecutive patients with varying grades of MR with echocardiography. MR was evaluated both qualitatively and quantitatively, and concordance of these 2 methods was determined. Peak E-wave velocity, A-wave velocity, and E-wave deceleration time were measured and the E/A ratio was calculated. LV isovolumetric relaxation and contraction times were measured. Different MR groups classified by RF were compared with each other.
RESULTS: Concordance of quantitative and qualitative evaluation was low in patients with low EF (kappa 0.37 vs 0.65). Peak E-wave velocity and E/A ratio showed significant differences between MR groups. Peak E-wave velocity correlated with the RF and EF (r = 0.47, r = 0.33, respectively, P <.001). Sensitivity, specificity, and negative predictive value of peak E-wave velocity >1.2 m/s suggesting severe MR were found to be different in patients with normal and low EF (96% vs 66%, 78% vs 83%, 97% vs 78%, respectively). E-wave deceleration, LV isovolumetric relaxation, and contraction time did not show a correlation with RF.
CONCLUSION: Peak E-wave velocity is a screening method that could be used in common for determining severity of MR semiquantitatively, especially in patients with normal EF.

Entities:  

Mesh:

Year:  2001        PMID: 11717613     DOI: 10.1067/mhj.2001.118465

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  2 in total

1.  Reduction in mitral regurgitation during therapy guided by measured filling pressures in the ESCAPE trial.

Authors:  Maryse Palardy; Lynne W Stevenson; Gudaye Tasissa; Michele A Hamilton; Robert C Bourge; Thomas G Disalvo; Uri Elkayam; James A Hill; Sharon C Reimold
Journal:  Circ Heart Fail       Date:  2009-04-14       Impact factor: 8.790

2.  Computational fluid dynamics modelling of left valvular heart diseases during atrial fibrillation.

Authors:  Stefania Scarsoglio; Andrea Saglietto; Fiorenzo Gaita; Luca Ridolfi; Matteo Anselmino
Journal:  PeerJ       Date:  2016-07-26       Impact factor: 2.984

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.